Sodium Polystyrene Sulfonate



Sodium Polystyrene Sulfonate





(soe’ dee um)

Kalexate, Kayexalate, Kionex, SPS

PREGNANCY CATEGORY C


Drug Class

Potassium-removing resin


Therapeutic Actions

An ion exchange resin that releases sodium ions in exchange for potassium ions as it passes along the intestine after oral administration or is retained in the colon after enema, thus reducing elevated serum potassium levels; action is limited and unpredictable.


Indications



  • Treatment of hyperkalemia



Available Forms

Suspension—15 g/60 mL; powder—454 g


Dosages

Adults

Oral

15–60 g/day PO, best given as 15 g daily to qid. Powder may be given as suspension with water or syrup (20–100 mL). May be introduced into stomach via nasogastric tube.

Enema

30–50 g every 6 hr given in appropriate vehicle and retained for 30–60 min or as long as possible.

Pediatric patients

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 21, 2016 | Posted by in NURSING | Comments Off on Sodium Polystyrene Sulfonate

Full access? Get Clinical Tree

Get Clinical Tree app for offline access